Francoise
Barre-Sinoussi Image source: CNN.com
|
A Nobel Laureate,
Francoise Barre-Sinoussi, says efforts are ongoing to develop a universal cure
for HIV and cancer through collaboration.
News
Agency of Nigeria report continues:
Barre-Sinoussi,
a co-discoverer of the HIV, said this in Paris while conducting some select
journalists on a tour of the sophisticated laboratories at Institut Pasteur.
The
News Agency of Nigeria reports that Barre-Sinoussi and Luc Montagnier
co-discovered the HIV in 1983.
She
also stated that the HIV Cure and Cancer Forum would on Saturday be inaugurated
at the Institut Curie in Paris.
“Efforts
are now underway to determine if these cancer therapies can be used to build up
the immune system of patients with HIV.
“This
will be in such a way that HIV patients can achieve a durable and perhaps
life-long treatment–free state of remission,’’ she said.
The
former IAS President said that many of the key immune pathways now being
therapeutically manipulated to cure cancer were first discovered in studies of
chronic viral infections, particularly HIV.
“We
know that controlling HIV in the absence of therapy will require the generation
and maintenance of powerful CD8+ or Killer-T cells that can target vulnerable
parts of the virus.
“The
challenge is remarkably similar to that in oncology where the goal of
innovative therapies is to generate Killer T cells that recognizes and clear
cancer cells.
“Timothy
Brown is the only person cured of HIV, and this was due to the work of a highly
resourceful team of Oncologists.
“His
case illustrates that we need to do more to incentivize scientists to work
across diseases and to ensure that research funding allows these synergies,”
she said.
The
Emeritus Director of Research at Inserm expressed optimism that synergy would
continue to strengthen the sciences and research.
IAS
President, Linda-Gail Bekker, on her part, said that continued support for
research was essential.
She
said the gathering in Paris would be used to inform the global community that
research cuts would reverse the progress made against HIV and put more lives at
risk.
NAN
reports that among those who led the IAS team round the laboratories were
Olivier Schwartz, Head of Virus and Immunity Unit and Asier Saez-Cirion, the
Team Leader, HIV and Inflammation Unit.
Also on the IAS team were Jean-Francois Delfraissy, Jean-Francois Chambon and Francois Dabis.
No comments:
Post a Comment